Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Trials Reimbursement Of Digital Self-Help Apps For Children With Anxiety

Executive Summary

Five digital mental health apps for children with low mood and anxiety are set to receive interim reimbursement via the UK’s early value assessment (EVA) pilot in a bid to tackle staff shortages and long waiting times for current interventions.

You may also be interested in...



Why NICE Is Building The Medtech Innovation Plane As It Flies

England’s NICE is ditching the rulebook in favor of “failing forward faster” when it comes to tackling medtech innovations. The organization’s interim director of medical technology says this approach mirrors the entrepreneurial nature of the medtech, diagnostics and digital sectors.

UK’s NICE Says ‘Light Touch’ HTA Evaluation Will Support Innovation

The UK’s health technology assessment body recognizes that its traditional product evaluation processes are too slow for innovative medtech products. Its new “conditional recommendation” pathway aims to fix this.

EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials

Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT146020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel